PDZ domains in synapse assembly and signalling CC Garner, J Nash, RL Huganir Trends in cell biology 10 (7), 274-280, 2000 | 700 | 2000 |
Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. RG Pertwee, SR Fernando, JE Nash, AA Coutts British journal of pharmacology 118 (8), 2199, 1996 | 222 | 1996 |
Interaction of SAP97 with minus-end-directed actin motor myosin VI: implications for AMPA receptor trafficking H Wu, JE Nash, P Zamorano, CC Garner Journal of Biological Chemistry 277 (34), 30928-30934, 2002 | 190 | 2002 |
Activation of the cannabinoid receptor by Δ9-tetrahydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus YP Maneuf, JE Nash, AR Crossman, JM Brotchie European journal of pharmacology 308 (2), 161-164, 1996 | 154 | 1996 |
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease JE Nash, SH Fox, B Henry, MP Hill, D Peggs, S McGuire, Y Maneuf, ... Experimental neurology 165 (1), 136-142, 2000 | 150 | 2000 |
Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease SL Thiele, R Warre, JE Nash JoVE (Journal of Visualized Experiments), e3234, 2012 | 144 | 2012 |
Interactions between Piccolo and the actin/dynamin-binding protein Abp1 link vesicle endocytosis to presynaptic active zones SD Fenster, MM Kessels, B Qualmann, WJ Chung, J Nash, ... Journal of Biological Chemistry 278 (22), 20268-20277, 2003 | 127 | 2003 |
The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP … JE Nash, P Ravenscroft, S McGuire, AR Crossman, FS Menniti, ... Experimental neurology 188 (2), 471-479, 2004 | 119 | 2004 |
Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat JE Nash, MP Hill, JM Brotchie Experimental neurology 155 (1), 42-48, 1999 | 111 | 1999 |
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease JE Nash, JM Brotchie Journal of Neuroscience 20 (20), 7782-7789, 2000 | 109 | 2000 |
Subcellular redistribution of the synapse‐associated proteins PSD‐95 and SAP97 in animal models of Parkinson&s disease and L‐DOPA‐induced dyskinesia JE Nash, TH Johnston, GL Collingridge, CC Garner, JM Brotchie The FASEB journal 19 (6), 1-25, 2005 | 96 | 2005 |
Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat JE Nash, JM Brotchie Movement Disorders: Official Journal of the Movement Disorder Society 17 (3 …, 2002 | 82 | 2002 |
Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in … SL Thiele, B Chen, C Lo, TS Gertler, R Warre, JD Surmeier, JM Brotchie, ... Neurobiology of disease 71, 334-344, 2014 | 81 | 2014 |
LTP in hippocampal neurons is associated with a CaMKII‐mediated increase in GluA1 surface expression VJ Appleby, SAL Corrêa, JK Duckworth, JE Nash, J Noël, SM Fitzjohn, ... Journal of neurochemistry 116 (4), 530-543, 2011 | 68 | 2011 |
Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism JA Gleave, LR Arathoon, D Trinh, KE Lizal, N Giguere, JHM Barber, ... Neurobiology of disease 106, 133-146, 2017 | 58 | 2017 |
Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses JE Nash, VJ Appleby, SAL Corrêa, H Wu, SM Fitzjohn, CC Garner, ... Journal of neurochemistry 112 (3), 677-690, 2010 | 55 | 2010 |
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease D Trinh, AR Israwi, LR Arathoon, JA Gleave, JE Nash Journal of Neurochemistry 156 (6), 715-752, 2021 | 43 | 2021 |
Plasma membrane Ca2+-ATPase associates with CLP36, α-actinin and actin in human platelets LD Bozulic, MT Malik, DW Powell, A Nanez, AJ Link, KS Ramos, WL Dean Thrombosis and haemostasis 97 (04), 587-597, 2007 | 43 | 2007 |
Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism R Warre, S Thiele, S Talwar, M Kamal, TH Johnston, S Wang, D Lam, ... Neurobiology of Disease 41 (3), 591-604, 2011 | 39 | 2011 |
Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson’s disease CJ Yong-Kee, E Sidorova, A Hanif, G Perera, JE Nash Neurotoxicity research 21, 185-194, 2012 | 33 | 2012 |